PHARMA & LIFE SCIENCES: LATEST INTERVIEWS MORE INTERVIEWS
"Digital transformation helps accelerate drug pipelines by reducing workload and increasing efficiency."
"From an innovation point of view, breaking the US$40/gram cost barrier for production of mAbs is a key objective this year."
"We balance the need for speed in drug development with strict regulatory requirements by focusing on robust data, sound justifications and a well-structured technical package."
"Small molecule drugs dominate pharmaceutical development, holding almost 60% of the market in 2024, and FDA approvals for small molecules are expected to stay strong."
PHARMA & LIFE SCIENCES: LATEST ARTICLES
Genome Editing Technologies: Beyond Science Fiction
December 03, 2024
Conciliating science and ethics
US Life Sciences: Oncology and CNS Lead the Way
October 31, 2024
Unprecedented strides in drug discovery and development mean growing hope for patients
PHARMA & LIFE SCIENCES: RECENTLY RELEASED PUBLICATIONS
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Mexico Chemicals 2025 CW Release
Mexico's chemical industry faces challenges in securing a reliable feedstock supply and maintaining global competitiveness. A shift towards sustainable energy and local production could provide long-term growth opportunities, and some sectors are booming, including Mexico's dynamic chemical distribution market.
Mexico's chemical industry faces challenges in securing a reliable feedstock supply and maintaining global competitiveness. A shift towards sustainable energy and local production could provide long-term growth opportunities, and some sectors are booming, including Mexico's dynamic chemical distribution market.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
